Bjørn Siteur

703 total citations
9 papers, 303 citations indexed

About

Bjørn Siteur is a scholar working on Molecular Biology, Oncology and Genetics. According to data from OpenAlex, Bjørn Siteur has authored 9 papers receiving a total of 303 indexed citations (citations by other indexed papers that have themselves been cited), including 7 papers in Molecular Biology, 4 papers in Oncology and 2 papers in Genetics. Recurrent topics in Bjørn Siteur's work include CRISPR and Genetic Engineering (3 papers), Epigenetics and DNA Methylation (3 papers) and RNA modifications and cancer (2 papers). Bjørn Siteur is often cited by papers focused on CRISPR and Genetic Engineering (3 papers), Epigenetics and DNA Methylation (3 papers) and RNA modifications and cancer (2 papers). Bjørn Siteur collaborates with scholars based in Netherlands, United States and South Korea. Bjørn Siteur's co-authors include Natalie Proost, Matteo Cesaroni, Maarten van Lohuizen, Michela Serresi, Danielle Hulsman, Gaetano Gargiulo, Jos Jonkers, Ivo J. Huijbers, Martine H. van Miltenburg and Marieke van de Ven and has published in prestigious journals such as Nucleic Acids Research, Nature Communications and The Journal of Experimental Medicine.

In The Last Decade

Bjørn Siteur

7 papers receiving 300 citations

Peers

Countries citing papers authored by Bjørn Siteur

Since Specialization

Citations

This map shows the geographic impact of Bjørn Siteur's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Bjørn Siteur with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Bjørn Siteur more than expected).

Fields of papers citing papers by Bjørn Siteur

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Bjørn Siteur. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Bjørn Siteur. The network helps show where Bjørn Siteur may publish in the future.

Co-authorship network of co-authors of Bjørn Siteur

This figure shows the co-authorship network connecting the top 25 collaborators of Bjørn Siteur. A scholar is included among the top collaborators of Bjørn Siteur based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Bjørn Siteur. Bjørn Siteur is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

9 of 9 papers shown

#	Work	Indexed citations
1	Large-scale Characterization of Orthotopic Cell Line–Derived Xenografts Identifies TGFβ Signaling as a Key Regulator of Breast Cancer Morphology and Aggressiveness 2025 ·Cancer Research ·Catrin Lutz, Xue Chao, (unknown), Jinhyuk Bhin, (unknown), (unknown), (unknown), (unknown), Natalie Proost, Bjørn Siteur, Marieke van de Ven, Ji‐Ying Song, Jacco van Rheenen, Jessica Morgner, Stefan Preković, Jos Jonkers	0
2	C-Terminal Truncation and Fusion Partner Determine Oncogenicity of FGFR3 2025 ·Cancer Research ·(unknown), Jinhyuk Bhin, Eline van der Burg, Anne Paulien Drenth, (unknown), Catrin Lutz, (unknown), Ellen Wientjens, Sjoerd Klarenbeek, (unknown), (unknown), Stefano Annunziato, Natalie Proost, Bjørn Siteur, (unknown), Marieke van de Ven, (unknown), Shridar Ganesan, (unknown), Daniel Zingg, (unknown)	0
3	Division of labor within the DNA damage tolerance system reveals non-epistatic and clinically actionable targets for precision cancer medicine 2022 ·Nucleic Acids Research ·Aldo Spanjaard, (unknown), (unknown), (unknown), Ben Morris, Cor Lieftink, Colin E.J. Pritchard, (unknown), (unknown), (unknown), Renske de Korte‐Grimmerink, Bjørn Siteur, Natalie Proost, (unknown), Marieke van de Ven, Ji‐Ying Song, Maaike Kreft, Paul C.M. van den Berk, Roderick L. Beijersbergen, Heinz Jacobs	6
4	QPCTL regulates macrophage and monocyte abundance and inflammatory signatures in the tumor microenvironment 2022 ·OncoImmunology ·Kaspar Bresser, Meike E. W. Logtenberg, Mireille Toebes, Natalie Proost, (unknown), Bjørn Siteur, (unknown), Lona J. Kroese, Ton N. Schumacher	16
5	Comparative oncogenomics identifies combinations of driver genes and drug targets in BRCA1-mutated breast cancer 2019 ·Nature Communications ·Stefano Annunziato, Julian R. de Ruiter, Linda Henneman, Chiara Svetlana Brambillasca, Catrin Lutz, François Vaillant, Federica Ferrante, Anne Paulien Drenth, Eline van der Burg, Bjørn Siteur, (unknown), Roebi de Bruijn, Martine H. van Miltenburg, Ivo J. Huijbers, Marieke van de Ven, Jane E. Visvader, Geoffrey J. Lindeman, Lodewyk F.A. Wessels, Jos Jonkers	54
6	Ezh2 inhibition in Kras-driven lung cancer amplifies inflammation and associated vulnerabilities 2018 ·The Journal of Experimental Medicine ·Michela Serresi, Bjørn Siteur, Danielle Hulsman, Matthias Jürgen Schmitt, Cor Lieftink, Ben Morris, Matteo Cesaroni, Natalie Proost, Roderick L. Beijersbergen, Maarten van Lohuizen, Gaetano Gargiulo	31
7	Modeling invasive lobular breast carcinoma by CRISPR/Cas9-mediated somatic genome editing of the mammary gland 2016 ·Genes & Development ·Stefano Annunziato, Sjors M. Kas, Micha Nethe, Hatice Yücel, (unknown), Colin E.J. Pritchard, Rahmen Bin Ali, (unknown), Bjørn Siteur, Anne Paulien Drenth, Eva Schut, Marieke van de Ven, Mirjam C. Boelens, Sjoerd Klarenbeek, Ivo J. Huijbers, Martine H. van Miltenburg, Jos Jonkers	100
8	Polycomb Repressive Complex 2 Is a Barrier to KRAS-Driven Inflammation and Epithelial-Mesenchymal Transition in Non-Small-Cell Lung Cancer 2016 ·Cancer Cell ·Michela Serresi, Gaetano Gargiulo, Natalie Proost, Bjørn Siteur, Matteo Cesaroni, Martijn Koppens, Huafeng Xie, (unknown), Danielle Hulsman, Elisabetta Citterio, Stuart H. Orkin, Anton Berns, Maarten van Lohuizen	5
9	Polycomb Repressive Complex 2 Is a Barrier to KRAS-Driven Inflammation and Epithelial-Mesenchymal Transition in Non-Small-Cell Lung Cancer 2016 ·Cancer Cell ·Michela Serresi, Gaetano Gargiulo, Natalie Proost, Bjørn Siteur, Matteo Cesaroni, Martijn Koppens, Huafeng Xie, (unknown), Danielle Hulsman, Elisabetta Citterio, Stuart H. Orkin, Anton Berns, Maarten van Lohuizen	91

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact